SC 13G Filing

Company

Caribou Biosciences, Inc.

Filed

January 8, 2024

Accession Number

0000919574-24-000156

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →